China Pharma Holdings (CPHI) Other Working Capital Changes (2016 - 2025)
China Pharma Holdings filings provide 16 years of Other Working Capital Changes readings, the most recent being -$46849.0 for Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 54.69% to -$46849.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$53444.0, a 93.88% decrease, with the full-year FY2025 number at -$53444.0, down 93.88% from a year prior.
- Other Working Capital Changes hit -$46849.0 in Q4 2025 for China Pharma Holdings, down from $178.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $656671.0 in Q3 2023 to a low of -$483110.0 in Q2 2023.
- Median Other Working Capital Changes over the past 5 years was -$6600.5 (2021), compared with a mean of -$2635.2.
- Biggest five-year swings in Other Working Capital Changes: skyrocketed 1007.48% in 2022 and later tumbled 1967.67% in 2023.
- China Pharma Holdings' Other Working Capital Changes stood at -$15106.0 in 2021, then skyrocketed by 1007.48% to $137084.0 in 2022, then plummeted by 225.9% to -$172583.0 in 2023, then soared by 82.45% to -$30285.0 in 2024, then crashed by 54.69% to -$46849.0 in 2025.
- The last three reported values for Other Working Capital Changes were -$46849.0 (Q4 2025), $178.0 (Q3 2025), and $41246.0 (Q2 2025) per Business Quant data.